18F-FDG uptake in lung, breast, and colon cancers: molecular biology correlates and disease characterization
about
Effect of Dietary ω-3 Polyunsaturated Fatty Acid DHA on Glycolytic Enzymes and Warburg Phenotypes in CancerRadioluminescence microscopy: measuring the heterogeneous uptake of radiotracers in single living cellsDevelopment of New Deoxycytidine Kinase Inhibitors and Noninvasive in Vivo Evaluation Using Positron Emission TomographyMechanisms underlying 18F-fluorodeoxyglucose accumulation in colorectal cancerBiomarkers in preclinical cancer imaging.Heterobivalent dual-target probe for targeting GRP and Y1 receptors on tumor cellsMultiple primary malignant tumors of upper gastrointestinal tract: a novel role of 18F-FDG PET/CT.Is higher lactate an indicator of tumor metastatic risk? A pilot MRS study using hyperpolarized (13)C-pyruvate.[(18)F](2S,4S)-4-(3-Fluoropropyl)glutamine as a tumor imaging agent.An observational study of circulating tumor cells and (18)F-FDG PET uptake in patients with treatment-naive non-small cell lung cancer.Tumor mechanics and metabolic dysfunction.Prognostic significance of baseline positron emission tomography and importance of clinical complete response in patients with esophageal or gastroesophageal junction cancer treated with definitive chemoradiotherapy.18F-fluorodeoxy-glucose positron emission tomography marks MYC-overexpressing human basal-like breast cancersPatient-Specific Method of Generating Parametric Maps of Patlak K(i) without Blood Sampling or Metabolite Correction: A Feasibility Study.Widefield optical imaging of changes in uptake of glucose and tissue extracellular pH in head and neck cancer.Influence of P-Glycoprotein Inhibition or Deficiency at the Blood-Brain Barrier on (18)F-2-Fluoro-2-Deoxy-D-glucose ( (18)F-FDG) Brain KineticsRecurrences after intensity modulated radiotherapy for head and neck squamous cell carcinoma more likely to originate from regions with high baseline [18F]-FDG uptakeMolecular Imaging of Membrane Transporters' Activity in Cancer: a Picture is Worth a Thousand Tubes.The preoperative SUVmax for (18)F-FDG uptake predicts survival in patients with colorectal cancer.Mild Alkalization Acutely Triggers the Warburg Effect by Enhancing Hexokinase Activity via Voltage-Dependent Anion Channel BindingPrognostic value of 18-fluorodeoxyglucose positron emission tomography-computed tomography in resectable colorectal cancer.Targeting lactate transport suppresses in vivo breast tumour growthPrognostic value of FDG PET/CT-based metabolic tumor volumes in metastatic triple negative breast cancer patientsCancer-generated lactic acid: a regulatory, immunosuppressive metabolite?Positron emission tomography-computed tomography in the management of lung cancer: An update.Methylglyoxal-Mediated Stress Correlates with High Metabolic Activity and Promotes Tumor Growth in Colorectal Cancer.Incidental focal hypermetabolic colorectal lesions identified by positron emission tomography: prevalence of malignancy.A new dimension of FDG-PET interpretation: assessment of tumor biology.Molecular mechanisms of metabolic reprogramming in proliferating cells: implications for T-cell-mediated immunity.Advanced endoscopic imaging for Barrett's Esophagus: current options and future directions.Positron emission tomography diagnostic imaging in multidrug-resistant hepatocellular carcinoma: focus on 2-deoxy-2-(18F)Fluoro-D-Glucose.Preoperative 18F-FDG PET/CT predicts disease-free survival in patients with primary invasive ductal breast cancer.18F-FDG uptake in breast cancer correlates with immunohistochemically defined subtypes.18 F-fluorodeoxyglucose uptake predicts pathological complete response after neoadjuvant chemotherapy for breast cancer: a retrospective cohort study.Non-invasive (89)Zr-Transferrin PET Shows Improved Tumor Targeting Compared to (18)F-FDG PET in MYC-overexpressing Human Triple Negative Breast Cancer.Prognostic value of positron emission tomography/computed tomography for adjuvant chemotherapy of colon cancer.Emerging clinical applications of PET based molecular imaging in oncology: the promising future potential for evolving personalized cancer care.Targeting metabolic reprogramming in KRAS-driven cancers.FDG-based quantitative comparison of glucose metabolism in vitro, exemplified by a head-to-head comparison between a triple-negative breast cancer cell line and a non-malignant foetal cell line.New Approach for Treatment of Primary Liver Tumors: The Role of Quercetin.
P2860
Q26784557-8F731306-A8C1-4787-8B34-A78050E01A7DQ27316441-26DD701C-895C-4967-8910-086F55D4C50AQ27679693-23345590-E557-4DA6-95E7-E254DF42EF9BQ28067736-6E301480-3FCF-41D9-9037-084665B785D9Q30416864-A594CF82-2116-432F-BBBD-78697FF786B5Q33804178-BFDB931D-069F-411D-8F23-EC65D7814459Q34073642-BEF04499-33F7-4289-A196-315EC7721AC7Q34213179-4E56E0EC-2516-4190-8CD0-D7055D7E38A4Q34473613-8E3D716B-E07C-45C8-8FEC-30DE284C85BDQ34826007-6B6C109D-D4AD-41F5-A8C6-EC26A806266AQ35117423-FEC63E02-EFCA-4D6E-A394-D28674DAEAB2Q35129698-9ED6F062-D0B1-4076-B1F8-773639387C68Q35141499-715253C5-53D2-4076-BB7D-1C7C0A02FB4CQ35201670-15ECAD70-4CB8-4D2B-99E2-F9887E21996AQ35349316-E4E4746F-7181-4916-8B98-8E1FEA61EC48Q35529180-77694D8F-E110-415E-AD3C-345E8B500AB4Q35747345-3F9D769B-8662-4790-89FB-7807FA68EADDQ35768413-962B65F3-CF7C-4265-8B99-0CF9FB7B08C2Q35874307-1D474EA2-7887-4C42-BCBF-824CF30316F6Q36091614-73125DA5-A9C6-4D3C-9967-1AC68DFBC29DQ36285794-0440FF86-B881-4E2D-BB39-9FA51A601427Q36326353-4B5AB62C-C9D8-47AE-8090-EDDF013E4F94Q36874902-B8B36A3B-CF6B-413A-9D9B-F673757A16D0Q37132414-379CEC2E-A66A-4BC2-B820-4DAF663D222DQ37481629-7CC7BADC-56AF-4A69-AA88-99BAA85964C9Q37631704-51CBDC36-19E6-4EBA-B45F-31596879DEA0Q37748532-60CA0CF5-4EF3-4C8F-B7D0-C26920989250Q37827752-4436D545-1D5D-4226-92BF-F39979ED3A46Q37989980-B3EEFFEB-0C69-48CD-9729-2938D68A9CBDQ37997633-3F255741-EEAD-4CAA-BA32-794AA9B7C75BQ38213800-BEB01AB3-A248-40FC-AF6B-91BC7C7ED685Q38269204-6A11D4E5-CA20-4287-A359-B6A2EA4FED3EQ38446353-27E28F58-4E55-4427-BE75-EBCFFD8D30DEQ38458792-C854A488-942A-4149-A26F-756F1825278FQ38605112-C751E156-31DA-445F-B41E-D5643B4C3E69Q38689156-B0DC32DE-E8A6-4671-AC6B-CAA76B91CBBEQ38692408-04736B70-BC56-4300-8732-F0CFFA1A5DA2Q38710288-E8D3F016-4246-4170-97CD-E4BB36D35600Q38764698-FB22D739-28EE-4A34-BF0C-4F206706C366Q38788907-8314BAD9-56A9-4A84-A17A-FE7E3F2BBF9F
P2860
18F-FDG uptake in lung, breast, and colon cancers: molecular biology correlates and disease characterization
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 16 October 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
18F-FDG uptake in lung, breast ...... s and disease characterization
@en
18F-FDG uptake in lung, breast ...... and disease characterization.
@nl
type
label
18F-FDG uptake in lung, breast ...... s and disease characterization
@en
18F-FDG uptake in lung, breast ...... and disease characterization.
@nl
prefLabel
18F-FDG uptake in lung, breast ...... s and disease characterization
@en
18F-FDG uptake in lung, breast ...... and disease characterization.
@nl
P2093
P2860
P1476
18F-FDG uptake in lung, breast ...... s and disease characterization
@en
P2093
Abass Alavi
Hossein Jadvar
Sanjiv S Gambhir
P2860
P304
P356
10.2967/JNUMED.108.054098
P407
P577
2009-10-16T00:00:00Z